Chemical compatibility of cefmetazole sodium with ranitidine hydrochloride during simulated Y-site administration. 1993

K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
School of Pharmacy, University of Southern California, Los Angeles 90033.

The stability of cefmetazole sodium and ranitidine hydrochloride was studied under conditions simulating administration via a Y-injection site into a primary infusion line. Cefmetazole sodium was reconstituted with both 0.9% sodium chloride injection (50 mL or 100 mL) and 5% dextrose injection (50 mL) to produce premixing concentrations of cefmetazole 10 and 20 mg/mL. Ranitidine hydrochloride injection was diluted with 50 mL 0.9% sodium chloride injection to give premixing concentrations of ranitidine 1 mg/mL. To simulate Y-site administration, 2 mL of cefmetazole was mixed with 2 mL of ranitidine in a 10-mL glass test tube. All study mixtures were prepared in triplicate and stored at room temperature (22-23 degrees C) under normal fluorescent room lighting. Samples of these admixtures were inspected for visual changes and tested for pH. The concentrations of two drugs were immediately determined by stability-indicating high-performance liquid chromatographic assay methods after mixing and at 1, 2, and 4 hours. No visual changes were observed. The pH in the admixtures was influenced by concentrations of the two drugs. The pH of each single-drug solution did not change during the study period. On the other hand, the pH of any admixtures of cefmetazole and ranitidine solutions prepared with 0.9% sodium chloride or 5% dextrose injection, decreased. Cefmetazole in any of the admixtures with ranitidine retained greater than 95% of its original concentration for 4 hours.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D011899 Ranitidine A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers. AH-19065,Biotidin,N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine,Ranisen,Ranitidin,Ranitidine Hydrochloride,Sostril,Zantac,Zantic,AH 19065,AH19065,Hydrochloride, Ranitidine
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D004355 Drug Stability The chemical and physical integrity of a pharmaceutical product. Drug Shelf Life,Drugs Shelf Lives,Shelf Life, Drugs,Drug Stabilities,Drugs Shelf Life,Drugs Shelf Live,Life, Drugs Shelf,Shelf Life, Drug,Shelf Live, Drugs,Shelf Lives, Drugs
D006863 Hydrogen-Ion Concentration The normality of a solution with respect to HYDROGEN ions; H+. It is related to acidity measurements in most cases by pH pH,Concentration, Hydrogen-Ion,Concentrations, Hydrogen-Ion,Hydrogen Ion Concentration,Hydrogen-Ion Concentrations
D015311 Cefmetazole A semisynthetic cephamycin antibiotic with a broad spectrum of activity against both gram-positive and gram-negative microorganisms. It has a high rate of efficacy in many types of infection and to date no severe side effects have been noted. CS-1170,Cefmetazole Monosodium Salt,Cefmetazole Sodium,Cefmetazon,U-72791A,Zefazone,CS 1170,CS1170,Monosodium Salt, Cefmetazole,Salt, Cefmetazole Monosodium,Sodium, Cefmetazole,U 72791A,U72791A

Related Publications

K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
April 2020, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
July 1995, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
January 2013, International journal of pharmaceutical compounding,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
May 1994, American journal of hospital pharmacy,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
October 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
January 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
September 1994, American journal of hospital pharmacy,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
May 1997, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
July 1994, American journal of hospital pharmacy,
K Inagaki, and M A Gill, and M P Okamoto, and J Takagi
September 1996, American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists,
Copied contents to your clipboard!